Mitchell Berenson
CEO
This company offers a cellular-connected infusion tracker that monitors patient adherence to medication schedules. The device analyzes patient-specific trends to predict future needs, enabling proactive healthcare management and improved patient outcomes.
Funding not disclosed

CEO
Patients undergoing home infusion therapy face challenges in adhering to prescribed medication schedules, which can lead to disease progression, increased hospitalization risk, and higher healthcare costs. Monitoring adherence is difficult and costly, hindering timely intervention and personalized care adjustments.
IV Ensure offers a remote therapeutic monitoring solution designed to improve patient adherence to home infusion therapy. The system uses a patented, cellular-connected device attached to the infusion line to track medication delivery and patient-reported feedback. This data is transmitted to care managers who provide 24/7 support and identify potential adherence issues. Insights from the monitoring are shared with the patient's physician, enabling informed decisions and proactive care management to improve health outcomes and reduce readmission rates.
The primary target audience includes chronically ill patients undergoing home infusion therapy, along with their physicians, home infusion providers, and insurance organizations.